INC Research names new VP of clinical development
This article was originally published in Scrip
The CRO INC Research has hired Dr Chris Smyth as its new senior vice-president of clinical development. In this role, Smyth will support the company's oncology development and service delivery efforts in Europe and Asia Pacific. Prior to joining INC Research, he was vice-president of clinical operations for Antisoma, specialising in the development of small molecules, biologicals and DNA aptamers for the treatment of cancer. Prior to this he also worked for the now defunct CRO MDS Pharma Services. He has been solely focused on haematology and oncology drug development since 2003.
You may also be interested in...
Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.
"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"